Moxifloxacin Analytical Method Validation-Assay |
Method Parameter |
Method Precision |
Std. wt. &
Dilution |
44.02 |
5 |
Tablet Wt. |
Spl. wt. &
Dilution |
Wt. of sample
taken |
5 |
Label claim
(mg) |
400 |
100 |
20 |
675.01 |
200 |
200 |
Potency (%) |
98.8 |
Molecular factor for Moxifloxacin |
0.917 |
|
|
|
|
Std. No. |
Standards |
USP
Tailing |
Weight of
sample taken |
Area of
sample |
Assay % |
Average
(%) |
STDEV |
% RSD |
1 |
2310915 |
1.54 |
1353.34 |
2337254 |
101.04 |
100.4 |
0.61837 |
0.62 |
2 |
2290693 |
1.54 |
1351.89 |
2321427 |
100.46 |
3 |
2300684 |
1.54 |
1358.15 |
2317128 |
99.81 |
4 |
2300777 |
1.54 |
1353.97 |
2341249 |
101.16 |
5 |
2300755 |
1.54 |
1355.02 |
2324067 |
100.34 |
|
|
|
1356.39 |
2310208 |
99.64 |
Average |
2300765 |
1.54 |
1354.79 |
2325222 |
100.41 |
STDEV |
7149.73 |
0.00 |
Limits |
% RSD of 6 replicate injections is not more than 2 |
%RSD |
0.31 |
0.0 |
|